Navigation Links
General Anxiety Disorder Global Clinical Trials Review, H2, 2013
Date:10/24/2013

London (PRWEB) October 24, 2013

General Anxiety Disorder Global Clinical Trials Review, H2, 2013

Summary

GlobalData's clinical trial report, “General Anxiety Disorder Global Clinical Trials Review, H2, 2013" provides data on the General Anxiety Disorder clinical trial scenario. This report provides elemental information and data relating to the clinical trials on General Anxiety Disorder. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating General Anxiety Disorder. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

-Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
-Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
-Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

-Understand the dynamics of a particular indication in a condensed manner
-Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
-Obtain discontinued trial listing for trials across the globe
-Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 7
Introduction 8
General Anxiety Disorder 8
Report Guidance 8
Clinical Trials by Region 9
Clinical Trials by Country 10
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12
Top Five Countries Contributing to Clinical Trials in Europe 13
Top Countries Contributing to Clinical Trials in North America 14
Top Countries Contributing to Clinical Trials in Middle East and Africa 15
Top Five Countries Contributing to Clinical Trials in Central and South America 16
Clinical Trials by BRIC Nations 17
Clinical Trials by G7 Nations 18
Clinical Trials in G7 Nations by Trial Status 19
Clinical Trials by E7 Nations 20
Clinical Trials in E7 Nations by Trial Status 21
Clinical Trials by Phase 22
In Progress Trials by Phase 23
Clinical Trials by Trial Status 24
Unaccomplished Trials of General Anxiety Disorder 25
Subjects Recruited Over a Period of Time 27
Prominent Sponsors 28
Top Companies Participating in General Anxiety Disorder Therapeutics Clinical Trials 30
Prominent Drug Comparison 32
Clinical Trial Profiles 33
Clinical Trial Overview of Top Companies 33
Pfizer Inc. 33
Clinical Trial Overview of Pfizer Inc. 33
Sanofi 35
Clinical Trial Overview of Sanofi 35
Eli Lilly and Company 36
Clinical Trial Overview of Eli Lilly and Company 36
Cephalon, Inc. 37
Clinical Trial Overview of Cephalon, Inc. 37
H. Lundbeck A/S 38
Clinical Trial Overview of H. Lundbeck A/S 38
Forest Laboratories, Inc. 39
Clinical Trial Overview of Forest Laboratories, Inc. 39
Merck & Co., Inc. 40
Clinical Trial Overview of Merck & Co., Inc. 40
Takeda Global Research and Development Center, Inc 41
Clinical Trial Overview of Takeda Global Research and Development Center, Inc 41
F. Hoffmann-La Roche Ltd. 42
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 42
AstraZeneca PLC 43
Clinical Trial Overview of AstraZeneca PLC 43
Bionomics Limited 44
Clinical Trial Overview of Bionomics Limited 44
Mylan Pharmaceuticals Inc. 45
Clinical Trial Overview of Mylan Pharmaceuticals Inc. 45
Fabre-Kramer Pharmaceuticals, Inc. 46
Clinical Trial Overview of Fabre-Kramer Pharmaceuticals, Inc. 46
Dr. Willmar Schwabe GmbH & Co. KG 47
Clinical Trial Overview of Dr. Willmar Schwabe GmbH & Co. KG 47
Torrent Pharmaceuticals Limited 48
Clinical Trial Overview of Torrent Pharmaceuticals Limited 48
Par Pharmaceutical Companies, Inc. 49
Clinical Trial Overview of Par Pharmaceutical Companies, Inc. 49
Mitsubishi Tanabe Pharma Corporation 50
Clinical Trial Overview of Mitsubishi Tanabe Pharma Corporation 50
Shire Plc 51
Clinical Trial Overview of Shire Plc 51
Sun Pharmaceutical Industries Limited 52
Clinical Trial Overview of Sun Pharmaceutical Industries Limited 52
Teva Pharmaceutical Industries Limited 53
Clinical Trial Overview of Teva Pharmaceutical Industries Limited 53
Clinical Trial Overview of Top Institutes / Government 54
National Institute of Mental Health 54
Clinical Trial Overview of National Institute of Mental Health 54
University of California, San Diego 55
Clinical Trial Overview of University of California, San Diego 55
The University of South Florida 56
Clinical Trial Overview of The University of South Florida 56
Institut de Recherches Internationales Servier 57
Clinical Trial Overview of Institut de Recherches Internationales Servier 57
Massachusetts General Hospital 58
Clinical Trial Overview of Massachusetts General Hospital 58
Baylor College of Medicine 59
Clinical Trial Overview of Baylor College of Medicine 59
University of Pennsylvania 60
Clinical Trial Overview of University of Pennsylvania 60
University of Pittsburgh 61
Clinical Trial Overview of University of Pittsburgh 61
The University of New South Wales 62
Clinical Trial Overview of The University of New South Wales 62
Duke University 63
Clinical Trial Overview of Duke University 63
Karolinska Institutet 64
Clinical Trial Overview of Karolinska Institutet 64
University of California, Los Angeles 65
Clinical Trial Overview of University of California, Los Angeles 65
University of Bristol 66
Clinical Trial Overview of University of Bristol 66
University Hospital, Linkoeping 67
Clinical Trial Overview of University Hospital, Linkoeping 67
Golestan University of Medical Sciences 68
Clinical Trial Overview of Golestan University of Medical Sciences 68
Creighton University 69
Clinical Trial Overview of Creighton University 69
Tabriz University 70
Clinical Trial Overview of Tabriz University 70
Haukeland University Hospital 71
Clinical Trial Overview of Haukeland University Hospital 71
University of Massachusetts 72
Clinical Trial Overview of University of Massachusetts 72
National Taiwan University Hospital 73
Clinical Trial Overview of National Taiwan University Hospital 73
Five Key Clinical Profiles 74
Appendix 145
Abbreviations 145
Definitions 145
Research Methodology 146
Secondary Research 146
About GlobalData 147
Contact Us 147
Disclaimer 147
Source 148

1.1 List of Tables

General Anxiety Disorder Therapeutics Market, Global, Clinical Trials by Zone, 2013* 9
General Anxiety Disorder Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 10
General Anxiety Disorder Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 11
General Anxiety Disorder Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2013* 12
General Anxiety Disorder Therapeutics Clinical Trials, Europe, Top Five Countries, 2013* 13
General Anxiety Disorder Therapeutics Clinical Trials, North America, Top Countries, 2013* 14
General Anxiety Disorder Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2013* 15
General Anxiety Disorder Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2013* 16
General Anxiety Disorder Therapeutics Clinical Trials, BRIC Countries, 2013* 17
General Anxiety Disorder Therapeutics Clinical Trials, G7 Countries, 2013* 18
General Anxiety Disorder Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 19
General Anxiety Disorder Therapeutics Clinical Trials, E7 Countries, 2013* 20
General Anxiety Disorder Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 21
General Anxiety Disorder Therapeutics Market, Global, Clinical Trials by Phase, 2013* 22
General Anxiety Disorder Therapeutics Market, Global, Clinical Trials In Progress by Phase 2013* 23
General Anxiety Disorder Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 24
General Anxiety Disorder Therapeutics Market, Global, Withdrawn Clinical Trials, 2013* 25
General Anxiety Disorder Therapeutics Market, Global, Terminated Clinical Trials, 2013* 26
General Anxiety Disorder Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 27
General Anxiety Disorder Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 29
General Anxiety Disorder Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 31
General Anxiety Disorder Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 32
General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2013* 33
General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2013* 35
General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by Eli Lilly and Company, 2013* 36
General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by Cephalon, Inc., 2013* 37
General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by H. Lundbeck A/S, 2013* 38
General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by Forest Laboratories, Inc., 2013* 39
General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2013* 40
General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by Takeda Global Research and Development Center, Inc, 2013* 41
General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by F. Hoffmann-La Roche Ltd., 2013* 42
General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by AstraZeneca PLC, 2013* 43
General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by Bionomics Limited, 2013* 44
General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by Mylan Pharmaceuticals Inc., 2013* 45
General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by Fabre-Kramer Pharmaceuticals, Inc., 2013* 46
General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by Dr. Willmar Schwabe GmbH & Co. KG, 2013* 47
General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by Torrent Pharmaceuticals Limited, 2013* 48
General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by Par Pharmaceutical Companies, Inc., 2013* 49
General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by Mitsubishi Tanabe Pharma Corporation, 2013* 50
General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by Shire Plc, 2013* 51
General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by Sun Pharmaceutical Industries Limited, 2013* 52
General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by Teva Pharmaceutical Industries Limited, 2013* 53
General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by National Institute of Mental Health, 2013* 54
General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Diego, 2013* 55
General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of South Florida, 2013* 56
General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by Institut de Recherches Internationales Servier, 2013* 57
General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by Massachusetts General Hospital, 2013* 58
General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by Baylor College of Medicine, 2013* 59
General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pennsylvania, 2013* 60
General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Pittsburgh, 2013* 61
General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of New South Wales, 2013* 62
General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by Duke University, 2013* 63
General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by Karolinska Institutet, 2013* 64
General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, Los Angeles, 2013* 65
General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Bristol, 2013* 66
General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital, Linkoeping, 2013* 67
General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by Golestan University of Medical Sciences, 2013* 68
General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by Creighton University, 2013* 69
General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by Tabriz University, 2013* 70
General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by Haukeland University Hospital, 2013* 71
General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Massachusetts, 2013* 72
General Anxiety Disorder Therapeutics Clinical Trials Market, Global, Clinical Trials by National Taiwan University Hospital, 2013* 73

List of Figures

General Anxiety Disorder Therapeutics Market, Global, Clinical Trials by Zone (%), 2013* 9
General Anxiety Disorder Therapeutics Market, Global, Clinical Trials by Top Countries, 2013* 10
General Anxiety Disorder Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2013* 11
General Anxiety Disorder Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2013* 12
General Anxiety Disorder Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2013* 13
General Anxiety Disorder Therapeutics Clinical Trials, North America, Top Countries (%), 2013* 14
General Anxiety Disorder Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2013* 15
General Anxiety Disorder Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2013* 16
General Anxiety Disorder Therapeutics Clinical Trials, BRIC Countries (%), 2013* 17
General Anxiety Disorder Therapeutics Clinical Trials, G7 Countries (%), 2013* 18
General Anxiety Disorder Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2013* 19
General Anxiety Disorder Therapeutics Clinical Trials, E7 Countries (%), 2013* 20
General Anxiety Disorder Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2013* 21
General Anxiety Disorder Therapeutics Market, Global, Clinical Trials by Phase (%), 2013* 22
General Anxiety Disorder Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2013* 23
General Anxiety Disorder Therapeutics Market, Global, Clinical Trials by Trial Status, 2013* 24
General Anxiety Disorder Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2007-2012 27
General Anxiety Disorder Therapeutics Clinical Trials, Global, Key Sponsors, 2013* 28
General Anxiety Disorder Therapeutics Clinical Trials, Global, Top Companies by Phase, 2013* 30
General Anxiety Disorder Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2013* 32
GlobalData Methodology 146

Read the full report:

General Anxiety Disorder Global Clinical Trials Review, H2, 2013

http://www.reportbuyer.com/pharma_healthcare/diseases/general_anxiety_disorder_global_clinical_trials_review_h2_2013.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pathology

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: query@reportbuyer.com
Tel: +44 208 816 85 48
Website: http://www.reportbuyer.com

Read the full story at http://www.prweb.com/releases/2013/10/prweb11266280.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved


Related medicine news :

1. Surgeon General receives 2012 Distinguished Public Service Award from internal medicine physicians
2. Australian general practitioners in training spend less time with peds patients than with adults
3. General surgeons identify postoperative complications posing strongest readmission risk
4. Survival After General Anesthesia Vastly Improved: Study
5. Risk factors in hospital readmissions among general surgery patients identified in study
6. General thoracic surgeons emerge as leading providers of complex, noncardiac thoracic surgery
7. General Plastics to Showcase High-Strength, Lightweight Composite Core Foams at COMPOSITES 2013 January 29-31
8. Neuroinflammation may be behind general-anesthesia-associated learning disabilities
9. Customers Can Buy General Hearing Instruments' Hearing Aids Online
10. Sika Sarnafil Wins Excellence In Design Award For General Motors Project
11. Fibromyalgia prevalence at 2.1 percent of general German population
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2016)... ... May 28, 2016 , ... In a part of the city where’s it’s easy to ... farm-to-table Kelowna restaurants is hoping to attract diners with a taste for real food. ... officially opened the doors to Cornerstone Grill, an urban casual restaurant focusing on dishes made ...
(Date:5/27/2016)... ... 27, 2016 , ... Two director-level employees of Horizon Blue Cross Blue Shield ... (TWIN) 2016 honorees. The award recognizes businesswomen who excel in their fields and ... of the MLTSS (Managed Long-Term Services and Supports) Program at Horizon NJ Health and ...
(Date:5/27/2016)... ... , ... With over 60 percent of acute stroke survivors being left unable ... aid in the rehabilitation process has steadily increased. Ekso Bionics had been working to ... to stroke. , Ekso Bionics has now received clearance from the U.S. Food and ...
(Date:5/27/2016)... ... May 27, 2016 , ... In ... the many who are unaware of the plight of aphasia. In collaboration with ... the “Stroke Awareness” campaign. , The link between stroke and aphasia is relatively ...
(Date:5/27/2016)... ... 2016 , ... Aimed at nurses and employees in the health care world, ... in the nursing and health care industry. It also provides insight to the developing ... , As the nursing industry is coming out of one of the biggest ...
Breaking Medicine News(10 mins):
(Date:5/24/2016)... , May 24, 2016 ... beide primären Endpunkte und demonstriert ... in ‚ausgezeichneter plus guter , ...    ,      (Logo: http://photos.prnewswire.com/prnh/20130829/633895-a ... heute neue positive Daten von der MORA-Studie der ...
(Date:5/24/2016)... CHRISTCHURCH, New Zealand , May 24, 2016 ... scanning and informatics solutions for the healthcare sector, has been ... the New Zealand Hi-Tech Awards 2016. Dr ... a fantastic acknowledgement for our team.  It,s really good to ... the burden healthcare internationally. Our products are used in 35 ...
(Date:5/24/2016)... INDIANAPOLIS , May 24, 2016  Joe Marziani has joined VMS BioMarketing as ... chief executive officer, today. In his new role, Marziani will lead the company,s business ... care professionals to improve outcomes. Photo - http://photos.prnewswire.com/prnh/20160523/371089 ... ... ...
Breaking Medicine Technology: